(Q34616004)

3 August 2017

1 reference

title

Biological therapy of colorectal cancer (English)

1 reference

3 August 2017

1 reference

1 reference

de Kleijn EM

1

1 reference

PubMed ID

11978526

3 August 2017

Punt CJ

series ordinal

2

1 reference

3 August 2017

1 May 2002

1 reference

European Journal of Cancer

3 August 2017

1 reference

3 August 2017

38

1 reference

3 August 2017

1016-1022

1 reference

3 August 2017

7

1 reference

The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Can immunotherapy by gene transfer tip the balance against colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Immunomodulation therapy in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

The role of biological response modifiers in the management of patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Phase I trial of murine monoclonal antibody L6 in combination with subcutaneous interleukin-2 in patients with advanced carcinoma of the breast, colorectum, and lung

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Preoperative Mobilization of Circulating Dendritic Cells by Flt3 Ligand Administration to Patients With Metastatic Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Modulation of CD4 cell cytokine production by colon cancer-associated mucin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Expression of the SART1 tumor-rejection antigens in colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900057-6

7 January 2021

10.1016/S0959-8049(02)00057-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11978526